April 29, 2020 / 1:10 PM / a month ago

BRIEF-Celon Pharma Gets Approval For Clinical Test Phase 1 Of GPR40 Receptor Agonist

April 29 (Reuters) - Celon Pharma SA:

* GETS APPROVAL FOR STARTING CLINICAL TESTS PHASE 1 OF GPR40 RECEPTOR AGONIST IN METABOLIC DISEASE TREATMENT Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below